EXPRESS PROTECT MULTI AKTIENANLEIHE - PFIZER INC/MODERNA/ROCHE GS Stock

Certificat

DE000VM505E0

Delayed Deutsche Boerse AG 08:04:54 2024-05-10 EDT
106.3 EUR +0.01% Intraday chart for EXPRESS PROTECT MULTI AKTIENANLEIHE - PFIZER INC/MODERNA/ROCHE GS
Current month+1.02%
1 month+0.89%
Date Price Change Volume
24-05-10 106.3 +0.01% 0
24-05-09 106.3 +0.01% 0
24-05-08 106.3 +0.96% 0
24-05-07 105.3 +0.01% 0
24-05-06 105.3 +0.03% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 08:04 am

More quotes

Static data

Product typeCertificats Divers
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM505E
ISINDE000VM505E0
Date issued 2023-11-29
Strike 236.3 CHF
Maturity 2025-02-28 (294 Days)
Parity 0.24 : 1
Emission price 100
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 106.3
Lowest since issue 97.09
Spread 10
Spread %0.93%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW